Literature DB >> 34278516

Chronic acquired hepatocerebral degeneration presenting with Meige's syndrome and behavioral symptoms fully reversed by liver transplantation.

Andrea Stracciari1, Luca Spinardi2, Maria Guarino2.   

Abstract

Chronic acquired hepatocerebral degeneration (CAHD) is a rare neurologic syndrome occurring in patients with chronic liver disease, resulting in the combination of movement disorders and cognitive\behavioral changes. Its pathogenesis is debated and the symptoms are poorly responsive to medical therapy. Meige's syndrome is a form of cranial dystonia, considered an idiopathic form of adult onset dystonia. We report a 60-year-old man with HCV-related liver cirrhosis and hepatocarcinoma who developed Meige's syndrome associated with cognitive and behavioral manifestations, unrelated to acute metabolic derangement. CAHD was diagnosed. Liver transplantation reversed the clinical picture and MR abnormalities, reinforcing the idea that CAHD is a potentially reversible syndrome, which may be healed by liver transplantation and should not be considered a contraindication for this operation.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Acquired hepatocerebral degeneration; Cognitive impairment; Liver transplantation; Meige’s syndrome; Movement disorders; Psychosis

Year:  2021        PMID: 34278516     DOI: 10.1007/s10072-021-05475-w

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  18 in total

1.  Acquired hepatocerebral degeneration: full recovery after liver transplantation.

Authors:  A Stracciari; M Guarino; P Pazzaglia; G Marchesini; P Pisi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

2.  Reversal of parkinsonism following liver transplantation.

Authors:  Lisa M Shulman; Alireza Minagar; William J Weiner
Journal:  Neurology       Date:  2003-02-11       Impact factor: 9.910

Review 3.  Acquired hepatocerebral degeneration.

Authors:  Wassilios Meissner; François Tison
Journal:  Handb Clin Neurol       Date:  2011

Review 4.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

5.  Improvement in chronic hepatocerebral degeneration following liver transplantation.

Authors:  E E Powell; M P Pender; J B Chalk; P J Parkin; R Strong; S Lynch; P Kerlin; W G Cooksley; W Cheng; L W Powell
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

Review 6.  Implications of Manganese in Chronic Acquired Hepatocerebral Degeneration.

Authors:  Neil Rajoriya; Mayur Brahmania; Jordan J Feld
Journal:  Ann Hepatol       Date:  2019 Jan - Feb       Impact factor: 2.400

Review 7.  The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration.

Authors:  M Victor; R D Adams; M Cole
Journal:  Medicine (Baltimore)       Date:  1965-09       Impact factor: 1.889

8.  Acquired hepatocerebral degeneration: MR and pathologic findings.

Authors:  J Lee; D Lacomis; S Comu; J Jacobsohn; E Kanal
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

9.  Cognitive functioning in chronic acquired hepatocerebral degeneration.

Authors:  Andrea Stracciari; Katia Mattarozzi; Roberto D'Alessandro; Elisa Baldin; Maria Guarino
Journal:  Metab Brain Dis       Date:  2008-04-24       Impact factor: 3.584

Review 10.  Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles.

Authors:  Karin Weissenborn
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

View more
  1 in total

Review 1.  Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview.

Authors:  Mohd Suhail; Sayed Sartaj Sohrab; Mohammad Amjad Kamal; Esam Ibraheem Azhar
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.